9.15
-0.2065(-2.21%)
Currency In USD
| Previous Close | 9.36 |
| Open | 8.87 |
| Day High | 9.47 |
| Day Low | 8.87 |
| 52-Week High | 43 |
| 52-Week Low | 3 |
| Volume | 13,199 |
| Average Volume | 6,522 |
| Market Cap | 6.99M |
| PE | -0.38 |
| EPS | -24 |
| Moving Average 50 Days | 8.64 |
| Moving Average 200 Days | 15.91 |
| Change | -0.21 |
If you invested $1000 in AIM ImmunoTech Inc. (AIM) 10 years ago, it would be worth $82.52 as of July 12, 2025 at a share price of $9.15. Whereas If you bought $1000 worth of AIM ImmunoTech Inc. (AIM) shares 5 years ago, it would be worth $3,630.95 as of July 12, 2025 at a share price of $9.15.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
AIM ImmunoTech Announces Recent Presentation on the Potential of Private-Public Partnerships for the Development of Oncology Therapies
GlobeNewswire Inc.
Jul 02, 2025 12:55 PM GMT
OCALA, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a presentation and discussion on immunotherapies involving AIM’s drug Ampligen at the recent U.S.-Poland Science and Te
AIM ImmunoTech Announces NYSE American Notice of Noncompliance With Minimum Stockholders’ Equity Requirements
GlobeNewswire Inc.
Jun 20, 2025 8:15 PM GMT
NYSE American previously issued similar warning for same matter and issued the new notice because the deficiency remains as of March 31, 2025 AIM has until June 11, 2026 to regain compliance OCALA, Fla., June 20, 2025 (GLOBE NEWSWIRE) -- AIM Immuno
AIM ImmunoTech Resumes Trading on NYSE American
GlobeNewswire Inc.
Jun 17, 2025 12:55 PM GMT
Company trading under the ticker “AIM” NYSE American effective at the start of trading today, Tuesday, June 17thOCALA, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it